Knowledge Tree
breast cancer
from single model dimensionNo definition has been generated yet — showing the first model analysis as a summary.
Breast cancer represents a significant global health burden, with the World Health Organization's 2024 report indicating 2.3 million new diagnoses and 670,000 deaths among women worldwide WHO 2024 global stats, and incidence rising from 875,657 cases in 1990 to 2,121,564 in 2021 global incidence increase. Various risk factors are implicated, including excessive estradiol and estrone levels linked to increased risk excessive estradiol risks estrone and cancer growth, hormone replacement therapy (HRT) associated with higher risks HRT risks, pro-inflammatory diets pro-inflammatory diets link, chronic inflammation chronic inflammation role, and sleep disorders like insomnia (HR 1.73) Taiwan sleep study. Protective factors include regular green tea consumption potentially reducing risk per large population studies green tea consumption and healthy lifestyles lowering risk via reduced systemic inflammation according to Zhang et al. (2024) healthy lifestyles mediation. Natural compounds show promise: Rabi and Bishayee (2009) reviewed terpenoids for chemoprevention terpenoids review, Wang et al. detailed silybin's autophagy induction via ROS silybin autophagy, and Karbasforooshan et al. (2019) found topical silymarin prevents radiodermatitis silymarin trial. Treatments include talazoparib for BRCA-mutated advanced cases per Litton et al. (2018) talazoparib treatment. Survivors face challenges like elevated allostatic load in Black women Black survivors allostatic load per Parente et al. (2013), greater physical declines from chemotherapy versus endocrine therapy per Clara Bodelon chemo physical declines, fatigue fatigue studies, and improving psychological outcomes post-treatment longitudinal psych study, with mastectomy linked to higher anxiety mastectomy anxiety. Research highlights bioelectric and epigenetic left-right differences by Masuelli et al. (2022, 2023) left-right differences. Contraindications include hormonal contraceptives and testosterone therapy contraindications TRT contraindication.
Model Perspectives (5)
openrouter/x-ai/grok-4.1-fast definitive 75% confidence
Breast cancer represents a significant global health burden, with the World Health Organization's 2024 report indicating 2.3 million new diagnoses and 670,000 deaths among women worldwide WHO 2024 global stats, and incidence rising from 875,657 cases in 1990 to 2,121,564 in 2021 global incidence increase. Various risk factors are implicated, including excessive estradiol and estrone levels linked to increased risk excessive estradiol risks estrone and cancer growth, hormone replacement therapy (HRT) associated with higher risks HRT risks, pro-inflammatory diets pro-inflammatory diets link, chronic inflammation chronic inflammation role, and sleep disorders like insomnia (HR 1.73) Taiwan sleep study. Protective factors include regular green tea consumption potentially reducing risk per large population studies green tea consumption and healthy lifestyles lowering risk via reduced systemic inflammation according to Zhang et al. (2024) healthy lifestyles mediation. Natural compounds show promise: Rabi and Bishayee (2009) reviewed terpenoids for chemoprevention terpenoids review, Wang et al. detailed silybin's autophagy induction via ROS silybin autophagy, and Karbasforooshan et al. (2019) found topical silymarin prevents radiodermatitis silymarin trial. Treatments include talazoparib for BRCA-mutated advanced cases per Litton et al. (2018) talazoparib treatment. Survivors face challenges like elevated allostatic load in Black women Black survivors allostatic load per Parente et al. (2013), greater physical declines from chemotherapy versus endocrine therapy per Clara Bodelon chemo physical declines, fatigue fatigue studies, and improving psychological outcomes post-treatment longitudinal psych study, with mastectomy linked to higher anxiety mastectomy anxiety. Research highlights bioelectric and epigenetic left-right differences by Masuelli et al. (2022, 2023) left-right differences. Contraindications include hormonal contraceptives and testosterone therapy contraindications TRT contraindication.
openrouter/x-ai/grok-4.1-fast definitive 85% confidence
Breast cancer represents a major global health burden, with the World Health Organization's 2024 report indicating 2.3 million new diagnoses among women and 670,000 deaths annually. Global incidence has risen sharply, from 875,657 cases in 1990 to 2,121,564 in 2021 global incidence rise. In China, it is the most common cancer among women and the fifth leading cause of cancer deaths, with 416,371 diagnoses in 2020 accounting for 18% of worldwide cases Chinese incidence 2020. A longitudinal study at Guangdong Provincial People’s Hospital recruited 143 Chinese women (mean age 42.27 years, SD=7.75) post-primary treatment, primarily involving mastectomy (84.6%), chemotherapy (86.7%), and radiotherapy (89.5%) study demographics. Participants showed decreasing trends in depression (from 3.50 to 1.24 over 48 months), anxiety (4.09 to 2.74), fear of cancer recurrence (21.72 to 18.70), and pain (12.96 to 11.50), alongside improved quality of life (87.77 to 93.42 by 12 months, then stable) psychological trends. Mastectomy was associated with higher anxiety at 48 months post-surgery compared to partial lumpectomy, with a least squares mean difference of -2.0996 in GAD-7 scores mastectomy anxiety; chemotherapy and radiotherapy had no significant long-term psychological impact. Outcomes of lumpectomy plus radiation and mastectomy are equivalent for early-stage disease, though mastectomy links to worse body image and chronic issues like pain and swelling. Survival rates have improved due to multimodal treatments, but with potential psychological costs survival improvements. Study limitations include small sample size and regional specificity, limiting generalizability study limitations.
openrouter/x-ai/grok-4.1-fast 75% confidence
Research on breast cancer highlights targeted therapies addressing specific molecular vulnerabilities. Serra V et al. in a 2019 Cancers (Basel) study identified a molecularly-defined subset of breast cancer models responsive to WEE1 or ATR inhibition, overcoming PARP inhibitor resistance Serra et al. WEE1/ATR subset. Hölzen et al. (2022) utilized RNA interference screens to reveal proteases as synthetic lethal partners with PI3K inhibition in breast cancer cells Hölzen proteases PI3K synthetic lethality. Bhat-Nakshatri et al. (2016) elucidated pathways from two common PIK3CA mutations in breast cancer Bhat-Nakshatri PIK3CA mutation pathways. A phase 3 trial published in the New England Journal of Medicine (2021) demonstrated adjuvant olaparib benefits for BRCA1- or BRCA2-mutated breast cancer patients olaparib adjuvant phase 3 trial. These studies from Serra, Hölzen, Bhat-Nakshatri teams, and NEJM trial emphasize precision approaches for mutation-driven breast cancer subtypes.
openrouter/x-ai/grok-4.1-fast definitive 75% confidence
Breast cancer, as reflected in the provided facts, is associated with significant psychological and quality-of-life (QoL) impacts on patients, particularly post-treatment. Longitudinal measurements indicate that breast cancer patients show a decreasing trend in depression, anxiety, pain, and fear of cancer recurrence over 48 months post-discharge, while QoL improves at 12 months and stabilizes thereafter. However, challenges persist, with the NEON-BC prospective study finding anxiety and depression persisting over five years post-diagnosis. Surgical choices influence outcomes, as mastectomy patients report higher anxiety than lumpectomy patients after 48 months, echoed in studies like Sun et al. (2013) comparing psychological effects of breast-conserving surgery versus modified radical mastectomy. Fear of cancer recurrence (FCR) negatively affects QoL, per Tran et al. (2022), with trajectories analyzed by Schapira et al. (2022) in young survivors. Pain prevalence post-treatment is reviewed by Wang et al. (2018), linked to QoL by Costa et al. (2017). Early research by M. J. Cordova et al. (1995) examined PTSD-like symptoms, while later works like Petrie et al. (1999) noted positive illness effects, and Tomich and Helgeson (2004) questioned benefit finding's universality. General overviews include Shah et al. (2014) on pathogenesis, prevention, diagnosis, and treatment, and Sharma et al. (2010) on types and management. Multiple systematic reviews, such as Maass et al. (2015) on long-term depression/anxiety and Breidenbach et al. (2022) on prevalence in survivors, highlight ongoing psych burdens, alongside treatment-specific effects like radiotherapy on anxiety per Parvizi et al. (2023). Overall, facts emphasize psychosocial sequelae over biological aspects.
openrouter/x-ai/grok-4.1-fast definitive 88% confidence
Breast cancer patients frequently experience symptom clusters, psychological distress, and diminished quality of life (QoL) due to treatments like radiotherapy, chemotherapy, surgery, and their side effects. So WK et al. systematic review identified symptom clusters across treatment stages, while radiodermatitis cohort study showed it impairs QoL during radiotherapy. Surgical interventions, such as mastectomy, negatively affect QoL, body image, and sexuality, as per Marinkovic et al. (2021), Han et al. (2010), and a 2021 Psicooncología review. Chemotherapy side effects and treatment trajectories also link to poorer health-related QoL and challenges like return to work, according to 2020 Medicine study and 2019 Eur J Cancer Care. Psychological issues are prevalent: Li et al. (2022) and Yang et al. (2023) analyzed anxiety/depression trajectories and fear of recurrence in Chinese patients, with Aggeli et al. (2021) noting post-treatment anxiety, depression, and sleep disorders. Persistent pain post-treatment was documented in Mejdahl et al. (2013) nationwide study. Targeted therapies address specific subtypes: HER2-targeted drugs like trastuzumab and tucatinib with capecitabine for metastatic cases tucatinib combo, hormone therapies for hormone-dependent tumors hormone therapy claim, and PARP inhibitors like Olaparib/Talazoparib for BRCA-positive or HRD tumors Olaparib expansion, Talazoparib use. Breast cancer ranks among top common cancers and synthetic lethality trial focuses common cancers, with genetic testing recommended by Ecaterina Dumbrava, M.D.. Personal accounts, like Cora Fahy (Stage 2A ER/PR+ Her2-) and Crystal A. Champion, highlight patient navigation using professional knowledge. Montazeri's (2008) review summarizes historical QoL literature.
Facts (91)
Sources
The influence of cancer treatments on long-term psychological ... link.springer.com Aug 30, 2025 34 facts
referenceThe study titled 'The impact of radiodermatitis on breast cancer patients’ quality of life during radiotherapy: a prospective cohort study' was published in J Pain Symptom Manage in 2019.
referenceDelikanli et al. (2023) studied the development of distress during a radiotherapy course in patients irradiated for breast cancer.
claimThe study titled "The influence of cancer treatments on long-term psychological outcomes and quality of life in breast cancer patients" was conducted in accordance with the Helsinki standard and received ethics approval from the Guangdong Provincial People’s Hospital Research Ethics Committee (ref No: 2018295H(R1)).
referenceMejdahl et al. (2013) conducted a six-year nationwide follow-up study on persistent pain and sensory disturbances after treatment for breast cancer.
claimThe researchers obtained informed consent from all participants in the study titled "The influence of cancer treatments on long-term psychological outcomes and quality of life in breast cancer patients".
referenceNg et al. (2015) conducted a 1-year prospective study on anxiety, depression, perceived social support, and quality of life in Malaysian breast cancer patients.
referenceThe study 'The effect on quality of life and body image of mastectomy among breast cancer survivors' was published in Eur J Breast Health in 2018.
referenceHan et al. (2010) studied quality of life and patient satisfaction after breast cancer operations.
referenceChemotherapy-induced adverse reactions are related to health-related quality of life in patients with breast cancer, according to a 2020 study published in Medicine (Baltimore).
referenceSo WK et al. (2021) conducted a systematic review of symptom clusters experienced by breast cancer patients at various stages of treatment.
referenceDelikanli C et al. (2023) studied the development of distress during a radiotherapy course in patients treated for breast cancer.
referenceMontazeri A (2008) provided a bibliographic review of literature from 1974 to 2007 regarding health-related quality of life in breast cancer patients.
claimThe study titled 'The influence of cancer treatments on long-term psychological outcomes and quality of life in breast cancer patients' was performed in accordance with the Helsinki standard.
referenceRadiodermatitis impacts the quality of life of breast cancer patients during radiotherapy, as established in a 2019 prospective cohort study published in the Journal of Pain and Symptom Management.
referenceThe article 'The influence of cancer treatments on long-term psychological outcomes and quality of life in breast cancer patients' is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
referenceThe study 'Return to work after breast cancer: the role of treatment-related side effects and potential impact on quality of life' was published in Eur J Cancer Care (Engl) in 2019.
referenceShi et al. (2011) compared the two-year quality of life outcomes for breast cancer patients across three different surgical procedures.
referenceAggeli P et al. (2021) investigated post-treatment anxiety, depression, sleep disorders, and associated factors in breast cancer survivors.
referenceThe systematic review 'The impact of mastectomy on body image and sexuality in women with breast cancer' was published in Psicooncología in 2021.
referenceEnien et al. (2018) examined the impact of surgery and treatment modality on the health-related quality of life in breast cancer patients.
claimThe study protocol for 'The influence of cancer treatments on long-term psychological outcomes and quality of life in breast cancer patients' was approved by the Guangdong Provincial People’s Hospital Research Ethics Committee under reference number 2018295H(R1).
referenceEnien MA et al. (2018) examined the impact of surgery and treatment modality on the health-related quality of life in breast cancer patients.
claimThe authors of 'The influence of cancer treatments on long-term psychological outcomes and quality of life in breast cancer patients' declare that they have no competing interests.
referenceMastectomy affects the quality of life and body image of breast cancer survivors, as discussed in a 2018 article in the European Journal of Breast Health.
referenceTreatment-related side effects influence the return to work and quality of life for breast cancer survivors, as reported in a 2019 study in the European Journal of Cancer Care.
referenceMastectomy impacts body image and sexuality in women with breast cancer, according to a 2021 systematic review published in Psicooncología.
referenceMarinkovic et al. (2021) assessed the quality of life in breast cancer patients depending on the type of surgical treatment.
referenceAggeli et al. (2021) studied post-treatment anxiety, depression, sleep disorders, and associated factors in women who survive breast cancer.
referenceMontazeri (2008) provided a bibliographic review of literature regarding health-related quality of life in breast cancer patients from 1974 to 2007.
referenceYang et al. (2023) investigated the predictors and trajectories of fear of cancer recurrence in Chinese breast cancer patients.
referenceLi et al. (2022) analyzed group-based trajectories and predictors of anxiety and depression among Chinese breast cancer patients.
referenceSo et al. (2021) conducted a systematic review of symptom clusters experienced by breast cancer patients at various treatment stages.
referenceShi H et al. (2011) compared the two-year quality of life outcomes across three different breast cancer surgical procedures.
referenceThe study 'Relationship between chemotherapy-induced adverse reactions and health-related quality of life in patients with breast cancer' was published in Medicine (Baltimore) in 2020.
Integrating allostasis and emerging technologies to study complex ... nature.com Nov 5, 2025 7 facts
claimThe allostatic load index, calculated by summing high-risk physiological biomarkers including systolic and diastolic blood pressure, BMI, fasting glucose, total cholesterol, HDL cholesterol, and CRP, was found to be elevated in black breast cancer survivors compared to black women without a cancer history.
claimMultimodal strategies that integrate clinical, imaging, and behavioral data with omics information are used to predict prognosis and design personalized treatments for complex diseases such as breast cancer.
claimPrevious studies on allostasis and cancer have largely focused on specific cancer types like breast and prostate cancer, which limits broader insights across other cancer types.
referenceStabellini, N. et al. (2024) investigated the relationship between allostatic load/chronic stress and cardiovascular outcomes in patients diagnosed with breast, lung, or colorectal cancer, published in the Journal of the American Heart Association.
referenceParente, V., Hale, L. & Palermo, T. (2013) analyzed the association between breast cancer and allostatic load by race using data from the National Health and Nutrition Examination Survey (1999–2008), published in Psycho-Oncology.
claimBlack breast cancer survivors exhibit an elevated allostatic load index compared to black women without a cancer history, suggesting a potential link between allostatic load and long-term prognosis in this population.
claimA study demonstrated the potential utility of the allostatic load index in predicting long-term health risks among breast cancer patients.
Reproductive Hormones endocrine.org Jan 24, 2022 4 facts
claimEstrone levels may require monitoring in women with breast cancer or in men undergoing testosterone-reducing treatments, such as prostate cancer therapy, because estrone levels can increase in these conditions.
claimHormone replacement therapy (HRT) is associated with increased risks of blood clots, heart disease, stroke, and breast cancer.
claimExcessive levels of estrone are linked to the growth of breast and endometrial cancer.
claimExcessive estradiol in women has been linked to acne, constipation, loss of sex drive, depression, and, if levels are extremely high, an increased risk of uterine cancer, breast cancer, and cardiovascular disease.
Crucial Answers on Long-Term Physical Health Effects From Breast ... cancernetwork.com Mar 24, 2025 4 facts
claimClara Bodelon, PhD, MS, a senior principal scientist of survivor research at the American Cancer Society, published a study in JAMA Network Open indicating that chemotherapy leads to more significant long-term physical health declines in breast cancer patients compared to endocrine therapy.
claimWomen who received chemotherapy for breast cancer experience long-term declines in physical health compared to cancer-free women of the same age, with these effects persisting beyond 5 years post-diagnosis.
claimWomen who received endocrine therapy for breast cancer show physical health outcomes similar to cancer-free women of the same age after the first 2 years post-diagnosis, suggesting they do not experience long-lasting physical health effects.
claimClara Bodelon stated that breast cancer survivors experience greater physical health declines compared to women who did not have breast cancer, a trend observed in previous research.
Positive and negative psychosocial impacts on cancer ... nature.com 4 facts
referenceA systematic review by Araújo, Simões, and Costa (2022) examined the influence of psychological factors on the risk of developing breast and lung cancer.
referenceGroarke, A., Curtis, R., and Kerin, M. published 'Global stress predicts both positive and negative emotional adjustment at diagnosis and post-surgery in women with breast cancer' in the journal Psychooncology in 2013.
referenceBouskill, K. and Kramer, M. published 'The impact of cancer and quality of life among long-term survivors of breast cancer in Austria' in the journal Support Care Cancer in 2016.
claimSchover, L. R. studied the impact of breast cancer on sexuality, body image, and intimate relationships in a 1991 article published in CA: A Cancer Journal for Clinicians.
Extent and Health Consequences of Chronic Sleep Loss and ... - NCBI ncbi.nlm.nih.gov 3 facts
referenceBerger and Higginbotham (2000) conducted a pilot study on the correlates of fatigue in patients during and following adjuvant breast cancer chemotherapy.
referenceBroeckel JA, Jacobsen PB, Horton J, Balducci L, and Lyman GH published a study titled 'Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer' in the Journal of Clinical Oncology in 1998 (Volume 16, Issue 5, pages 1689–1696).
referenceCarpenter JS et al. studied hot flashes and related outcomes in breast cancer survivors compared to matched women, published in the Oncological Nursing Forum in 2002.
Cancer Rehabilitation - Cancer Nation (Formerly NCCS) canceradvocacy.org 3 facts
accountCora Fahy was diagnosed with Stage 2A ER/PR+ Her2- IDC Multifocal Multicentric breast cancer in 2015 and utilized her professional knowledge of pathology, treatment, and prognosis to navigate her recovery and survivorship.
accountCrystal A. Champion received a breast cancer diagnosis in December 2019 and utilized the same professional advice she had previously provided to her patients to navigate her own treatment and recovery.
accountMarie Michel, a breast cancer survivor, utilized ReVital Cancer Rehabilitation to regain the strength required to perform everyday tasks independently following chemotherapy and surgery.
Peer-Reviewed Papers - The Levin Lab drmichaellevin.org 3 facts
referenceMasuelli, S., Real, S., McMillen, P., Oudin, M., Levin, M., and Roqué, M. published 'The Yin and Yang of Breast Cancer: Ion Channels as Determinants of Left-Right Functional Differences' in the International Journal of Molecular Sciences in 2023.
referenceThe paper 'Potential Shortcomings of Genomic Database: The Case of Nav1.5 Expression in Breast Cancer' was authored by M.B.A. Djamgoz and Michael Levin and published in the journal Bioelectricity in 2024.
referenceMasuelli et al. published 'When left does not seem right: epigenetic and bioelectric differences between left- and right-sided breast cancer' in Molecular Medicine in 2022, identifying bioelectric differences between left- and right-sided breast cancer.
Phytochemical and Pharmacological Studies of Traditionally Used ... heraldopenaccess.us 3 facts
claimTorres et al. (2018) found that Ocimum basilicum, but not Ocimum gratissimum, presents cytotoxic effects on the human breast cancer cell line MCF-7, inducing apoptosis and triggering the mTOR/Akt/p70S6K pathway.
claimSilybin induces autophagy in breast cancer via ROS-dependent mitochondrial dysfunction and loss of ATP involving BNIP3; it also prevents TPA and PMA induced MMP-9 expression and VEGF secretion via inactivation of the Raf/MEK/ERK pathway and blockade of AP-1 activation via MAPK signaling pathways, according to Wang et al. [101].
referenceTopical silymarin administration is effective for the prevention of acute radiodermatitis in breast cancer patients, according to a 2019 randomized, double-blind, placebo-controlled clinical trial by Karbasforooshan et al.
How to reduce inflammation in the body - MD Anderson Cancer Center mdanderson.org Mar 20, 2026 2 facts
claimPro-inflammatory diets are linked to higher risks of esophageal, oral, pharynx, breast, lung, colorectal, and stomach cancer.
claimChronic inflammation contributes to the initiation, progression, and spread of cancers, including colorectal, lung, stomach, esophageal, breast, and liver cancer, by damaging DNA, promoting cell proliferation, and creating an environment that favors tumor growth.
Medicinal plants: bioactive compounds, biological activities ... frontiersin.org 2 facts
claimNatural alkaloids from Dicranostigma leptopodum (Maxim.) fedde and their G5. NHAc-PBA dendrimer-alkaloid complexes were evaluated for targeting chemotherapy in breast cancer MCF-7 cells.
referenceSelected Nigerian medicinal plants demonstrate antiproliferative activities against breast, liver, and cervical cancer cells, according to a 2024 study.
Male menopause: Myth or reality? - Mayo Clinic mayoclinic.org Mar 26, 2025 2 facts
claimTestosterone therapy might increase the risk of prostate and breast cancer, though more research is needed to confirm this.
claimHealthcare professionals may recommend against testosterone therapy for men with a history of breast or prostate cancer, untreated severe obstructive sleep apnea, uncontrolled heart failure, a history of blood clots in the legs or lungs, or a recent heart attack or stroke.
Cancer survivorship and long-term outcomes: navigating the ... sci-rep.com Oct 23, 2024 2 facts
referenceLengacher CA et al. examined symptoms and symptom clusters in post-treatment breast cancer patients using mindfulness-based stress reduction.
referenceLengacher CA, Reich RR, Post-White J, Moscoso MS, Shelton MM, Barta M, et al. examined the use of mindfulness-based stress reduction in post-treatment breast cancer patients, focusing on symptoms and symptom clusters.
Meeting Psychosocial Health Needs of Cancer Survivors cancer.gov Jun 7, 2022 1 fact
measurementA study of breast cancer patients led by Erin Hahn at Kaiser Permanente Southern California found that fewer than 10% of patients screened for depression in community-based oncology practices required a special care referral.
Long-term and Late Effects of Cancer cancer.org Nov 24, 2025 1 fact
claimCertain cancer treatments increase the risk for a second (secondary) cancer, such as acute myelogenous leukemia after chemotherapy or breast cancer after radiation to the chest.
A Twist on Paleo: Eat What Your Family Ate—500 Years Ago nationalgeographic.com Mar 2, 2016 1 fact
accountBiologist Stephen Le began researching the relationship between diet and health after his mother passed away from breast cancer in 2010, leading him to question whether a diet based on human evolution was optimal for long-term health.
The breakthroughs behind UT MD Anderson's quest to end cancer nature.com 1 fact
claimBreast-tissue analysis has revealed that chromosomal abnormalities typically associated with cancer are also present in some healthy cells, which may alter the understanding of early breast cancer development.
Cellular senescence: from homeostasis to pathological implications ... frontiersin.org 1 fact
referenceOu B, Liu Y, Gao Z, Xu J, Yan Y, Li Y et al. reported in Cell Death & Disease (2022) that senescent neutrophil-derived exosomal piRNA-17560 promotes chemoresistance and epithelial-mesenchymal transition (EMT) in breast cancer via FTO-mediated m6A demethylation.
Measurement of diets that are healthy, environmentally sustainable ... frontiersin.org 1 fact
claimThere is a lack of composite metrics in the sustainable diets literature that reflect overall 'health' rather than specific disease outcomes, with only one composite health indicator identified: the rate advancement period, which incorporates all-cause mortality, cardiovascular disease, breast cancer, and type 2 diabetes.
Cancer Survivorship Programs and Clinics cancer.org Oct 21, 2025 1 fact
claimSome cancer survivorship programs offer specialized clinics tailored to specific cancer types, such as breast cancer, blood cancers, or childhood cancers, which may require travel if not available at a local cancer center.
Western pattern diet - Wikipedia en.wikipedia.org 1 fact
claimNo significant relation has been established between the Western pattern diet and breast cancer.
The Good, The Bad and the Ugly of Inflammation medschool.vanderbilt.edu Feb 10, 2015 1 fact
claimCertain cancers, specifically colon and breast cancer, express IL-4 and IL-13 receptors, which allows inflammatory cytokines to trigger rapid tumor growth and metastasis.
Understanding Male Hormonal Changes: A Complete Guide (2025) coremedicalwellness.com Oct 21, 2025 1 fact
claimTestosterone Replacement Therapy (TRT) is contraindicated in men with certain conditions, including prostate or breast cancer.
Bridging the Gap Between LLMs and Evolving Medical Knowledge arxiv.org Jun 29, 2025 1 fact
claimA past medical history of breast cancer contraindicates hormonal contraceptives, but copper IUDs are considered safe for these patients.
Medicinal plants and human health: a comprehensive review of ... link.springer.com Nov 5, 2025 1 fact
claimLarge population studies suggest that regular green tea consumption may reduce the risk of breast, prostate, and colorectal cancers.
Vernonia amygdalina: a comprehensive review of the ... frontiersin.org 1 fact
referenceRabi T. and Bishayee A. (2009) reviewed the role of terpenoids in breast cancer chemoprevention.
Stress, Lifestyle, and Health – Introduction to Psychology open.maricopa.edu 1 fact
claimHigher levels of social support are linked to better survival rates following breast cancer and infectious diseases, specifically HIV infection.
Editorial: Inflammation and chronic disease - Frontiers frontiersin.org Jul 1, 2024 1 fact
claimHealthy lifestyles are associated with systemic inflammation and breast cancer risk, with systemic inflammation acting as a mediator, according to a 2024 analysis by Zhang et al.
Chronic inflammation in the etiology of disease across the life span nature.com Dec 5, 2019 1 fact
referenceA 2016 systematic review and meta-analysis in Cancer Epidemiology, Biomarkers & Prevention examined the effect of exercise training on mediators of inflammation in breast cancer survivors.
Sleep Deprivation Can Lead to a Plethora of Diseases bergerhenryent.com Jan 26, 2019 1 fact
claimAlzheimer’s disease kills more people than breast cancer and prostate cancer combined.
Short- and long-term health consequences of sleep disruption dovepress.com May 19, 2017 1 fact
measurementA large nested case–control study from Taiwan determined an increased risk of breast cancer among patients with sleep disorders, with adjusted hazard ratios of 1.73 (95% CI, 1.57–1.90) for insomnia, 2.76 (95% CI, 1.53–5.00) for parasomnia, and 2.10 (95% CI, 1.16–3.80) for obstructive sleep apnea.